Comparing a Guideline-Based Mobile Health Intervention Versus Usual Care for High-Risk Adolescents With Asthma: Protocol of a Randomized Controlled Trial
BackgroundMobile health (mHealth) technology has the ability to integrate personalized health management into patients’ daily routines. In prior investigations of mHealth apps for asthma, patient satisfaction and acceptability have been high. However, rigorous randomized cont...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JMIR Publications
2025-07-01
|
| Series: | JMIR Research Protocols |
| Online Access: | https://www.researchprotocols.org/2025/1/e69903 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849251947667783680 |
|---|---|
| author | Tamara T Perry Jessica H Turner Ariel Berlinski Larry A Simmons Rita H Brown Kaymon Neal Sarah A Marshall Xing He Simon Chung Andrew Brown Horace J Spencer 3rd Jiang Bian |
| author_facet | Tamara T Perry Jessica H Turner Ariel Berlinski Larry A Simmons Rita H Brown Kaymon Neal Sarah A Marshall Xing He Simon Chung Andrew Brown Horace J Spencer 3rd Jiang Bian |
| author_sort | Tamara T Perry |
| collection | DOAJ |
| description |
BackgroundMobile health (mHealth) technology has the ability to integrate personalized health management into patients’ daily routines. In prior investigations of mHealth apps for asthma, patient satisfaction and acceptability have been high. However, rigorous randomized controlled trials (RCTs) examining their effectiveness are sparse; the majority of mHealth asthma apps lack personalization and real-time feedback and fail to include at-risk pediatric populations, and many previous studies are not randomized.
ObjectiveThis full-scale RCT will examine the effectiveness of the Pulmonary Education and Asthma Knowledge Mobile Asthma Action Plan (PEAKmAAP), an interactive mHealth asthma action plan (mAAP) smartphone app, among adolescents compared to enhanced usual care (eUC). The study has 3 aims: (1) examine the effectiveness of PEAKmAAP in reducing asthma morbidity, as measured by the Asthma Control Test (ACT) score, health care use, medication use, and lung function; (2) examine the effectiveness of PEAKmAAP in asthma self-efficacy and medication adherence; and (3) examine the impact of sharing PEAKmAAP-generated data with the primary care provider (PCP) for a subset of enrolled subjects. We hypothesize that the PEAKmAAP groups will experience reduced asthma morbidity compared to the eUC group. Furthermore, we hypothesize that PCP data sharing is expected to enhance PCP prescribing patterns and that more adolescents in the Pulmonary Education and Asthma Knowledge Mobile Asthma Action Plan with data sharing (PEAKmAAP-DS) group will have sustained controlled at follow-up visits compared to PEAKmAAP alone or eUC.
MethodsUsing a 3-arm RCT lasting 12 months, we will assess the effectiveness of PEAKmAAP in reducing morbidity among 432 adolescents (age 12-20 years). The study population includes adolescents with uncontrolled symptoms who receive primary care at the Arkansas Children’s Hospital (ACH) or asthma care at ACH specialty clinics. At baseline, participants are randomly assigned to 1 of 3 groups: (1) PEAKmAAP group, (2) PEAKmAAP-DS group, and (3) eUC group using a smartphone app with daily non–asthma-related notifications. Study procedures will include baseline, 3-month, and 12-month in-person visits and telephone visits at 6 and 9 months. In-person visits will measure the ACT score, lung function, and self-efficacy; telephone visits will measure the ACT score. Participants will complete monthly online surveys to assess health care use and medication use.
ResultsRecruitment and data collection began in March 2019, and data collection concluded in May 2024. Full data analysis began in December 2024.
ConclusionsThis RCT aims to examine the effectiveness of a mAAP with real-time feedback and PCP data sharing. The study addresses existing gaps in knowledge regarding implementation of a mAAP for high-risk adolescents and has the potential to serve as a model for other populations at high risk for asthma.
Trial RegistrationClinicalTrials.gov NCT03842033; https://clinicaltrials.gov/study/NCT03842033
International Registered Report Identifier (IRRID)DERR1-10.2196/69903 |
| format | Article |
| id | doaj-art-bd9a3dff029044cd82a7050af465830e |
| institution | Kabale University |
| issn | 1929-0748 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | JMIR Publications |
| record_format | Article |
| series | JMIR Research Protocols |
| spelling | doaj-art-bd9a3dff029044cd82a7050af465830e2025-08-20T03:56:46ZengJMIR PublicationsJMIR Research Protocols1929-07482025-07-0114e6990310.2196/69903Comparing a Guideline-Based Mobile Health Intervention Versus Usual Care for High-Risk Adolescents With Asthma: Protocol of a Randomized Controlled TrialTamara T Perryhttps://orcid.org/0000-0003-1319-3465Jessica H Turnerhttps://orcid.org/0009-0002-6736-1399Ariel Berlinskihttps://orcid.org/0000-0002-4010-3659Larry A Simmonshttps://orcid.org/0009-0002-9305-750XRita H Brownhttps://orcid.org/0009-0001-8194-6265Kaymon Nealhttps://orcid.org/0009-0001-8867-619XSarah A Marshallhttps://orcid.org/0000-0003-4367-7866Xing Hehttps://orcid.org/0000-0003-0290-8058Simon Chunghttps://orcid.org/0000-0003-2349-3779Andrew Brownhttps://orcid.org/0000-0002-1758-8205Horace J Spencer 3rdJiang Bianhttps://orcid.org/0000-0002-2238-5429 BackgroundMobile health (mHealth) technology has the ability to integrate personalized health management into patients’ daily routines. In prior investigations of mHealth apps for asthma, patient satisfaction and acceptability have been high. However, rigorous randomized controlled trials (RCTs) examining their effectiveness are sparse; the majority of mHealth asthma apps lack personalization and real-time feedback and fail to include at-risk pediatric populations, and many previous studies are not randomized. ObjectiveThis full-scale RCT will examine the effectiveness of the Pulmonary Education and Asthma Knowledge Mobile Asthma Action Plan (PEAKmAAP), an interactive mHealth asthma action plan (mAAP) smartphone app, among adolescents compared to enhanced usual care (eUC). The study has 3 aims: (1) examine the effectiveness of PEAKmAAP in reducing asthma morbidity, as measured by the Asthma Control Test (ACT) score, health care use, medication use, and lung function; (2) examine the effectiveness of PEAKmAAP in asthma self-efficacy and medication adherence; and (3) examine the impact of sharing PEAKmAAP-generated data with the primary care provider (PCP) for a subset of enrolled subjects. We hypothesize that the PEAKmAAP groups will experience reduced asthma morbidity compared to the eUC group. Furthermore, we hypothesize that PCP data sharing is expected to enhance PCP prescribing patterns and that more adolescents in the Pulmonary Education and Asthma Knowledge Mobile Asthma Action Plan with data sharing (PEAKmAAP-DS) group will have sustained controlled at follow-up visits compared to PEAKmAAP alone or eUC. MethodsUsing a 3-arm RCT lasting 12 months, we will assess the effectiveness of PEAKmAAP in reducing morbidity among 432 adolescents (age 12-20 years). The study population includes adolescents with uncontrolled symptoms who receive primary care at the Arkansas Children’s Hospital (ACH) or asthma care at ACH specialty clinics. At baseline, participants are randomly assigned to 1 of 3 groups: (1) PEAKmAAP group, (2) PEAKmAAP-DS group, and (3) eUC group using a smartphone app with daily non–asthma-related notifications. Study procedures will include baseline, 3-month, and 12-month in-person visits and telephone visits at 6 and 9 months. In-person visits will measure the ACT score, lung function, and self-efficacy; telephone visits will measure the ACT score. Participants will complete monthly online surveys to assess health care use and medication use. ResultsRecruitment and data collection began in March 2019, and data collection concluded in May 2024. Full data analysis began in December 2024. ConclusionsThis RCT aims to examine the effectiveness of a mAAP with real-time feedback and PCP data sharing. The study addresses existing gaps in knowledge regarding implementation of a mAAP for high-risk adolescents and has the potential to serve as a model for other populations at high risk for asthma. Trial RegistrationClinicalTrials.gov NCT03842033; https://clinicaltrials.gov/study/NCT03842033 International Registered Report Identifier (IRRID)DERR1-10.2196/69903https://www.researchprotocols.org/2025/1/e69903 |
| spellingShingle | Tamara T Perry Jessica H Turner Ariel Berlinski Larry A Simmons Rita H Brown Kaymon Neal Sarah A Marshall Xing He Simon Chung Andrew Brown Horace J Spencer 3rd Jiang Bian Comparing a Guideline-Based Mobile Health Intervention Versus Usual Care for High-Risk Adolescents With Asthma: Protocol of a Randomized Controlled Trial JMIR Research Protocols |
| title | Comparing a Guideline-Based Mobile Health Intervention Versus Usual Care for High-Risk Adolescents With Asthma: Protocol of a Randomized Controlled Trial |
| title_full | Comparing a Guideline-Based Mobile Health Intervention Versus Usual Care for High-Risk Adolescents With Asthma: Protocol of a Randomized Controlled Trial |
| title_fullStr | Comparing a Guideline-Based Mobile Health Intervention Versus Usual Care for High-Risk Adolescents With Asthma: Protocol of a Randomized Controlled Trial |
| title_full_unstemmed | Comparing a Guideline-Based Mobile Health Intervention Versus Usual Care for High-Risk Adolescents With Asthma: Protocol of a Randomized Controlled Trial |
| title_short | Comparing a Guideline-Based Mobile Health Intervention Versus Usual Care for High-Risk Adolescents With Asthma: Protocol of a Randomized Controlled Trial |
| title_sort | comparing a guideline based mobile health intervention versus usual care for high risk adolescents with asthma protocol of a randomized controlled trial |
| url | https://www.researchprotocols.org/2025/1/e69903 |
| work_keys_str_mv | AT tamaratperry comparingaguidelinebasedmobilehealthinterventionversususualcareforhighriskadolescentswithasthmaprotocolofarandomizedcontrolledtrial AT jessicahturner comparingaguidelinebasedmobilehealthinterventionversususualcareforhighriskadolescentswithasthmaprotocolofarandomizedcontrolledtrial AT arielberlinski comparingaguidelinebasedmobilehealthinterventionversususualcareforhighriskadolescentswithasthmaprotocolofarandomizedcontrolledtrial AT larryasimmons comparingaguidelinebasedmobilehealthinterventionversususualcareforhighriskadolescentswithasthmaprotocolofarandomizedcontrolledtrial AT ritahbrown comparingaguidelinebasedmobilehealthinterventionversususualcareforhighriskadolescentswithasthmaprotocolofarandomizedcontrolledtrial AT kaymonneal comparingaguidelinebasedmobilehealthinterventionversususualcareforhighriskadolescentswithasthmaprotocolofarandomizedcontrolledtrial AT sarahamarshall comparingaguidelinebasedmobilehealthinterventionversususualcareforhighriskadolescentswithasthmaprotocolofarandomizedcontrolledtrial AT xinghe comparingaguidelinebasedmobilehealthinterventionversususualcareforhighriskadolescentswithasthmaprotocolofarandomizedcontrolledtrial AT simonchung comparingaguidelinebasedmobilehealthinterventionversususualcareforhighriskadolescentswithasthmaprotocolofarandomizedcontrolledtrial AT andrewbrown comparingaguidelinebasedmobilehealthinterventionversususualcareforhighriskadolescentswithasthmaprotocolofarandomizedcontrolledtrial AT horacejspencer3rd comparingaguidelinebasedmobilehealthinterventionversususualcareforhighriskadolescentswithasthmaprotocolofarandomizedcontrolledtrial AT jiangbian comparingaguidelinebasedmobilehealthinterventionversususualcareforhighriskadolescentswithasthmaprotocolofarandomizedcontrolledtrial |